908 Devices (MASS) IPO Opens 128% Higher

Today's IPO for 908 Devices Inc. (NASDAQ: MASS) opened for trading at $45.51 after pricing 6,500,000 shares at $20.00 per share.

In addition, the underwriters have been granted a 30-day option to purchase up to an additional 975,000 shares of common stock from the Company at the public offering price.

Cowen and SVB Leerink acted as lead book-running managers for the proposed offering. William Blair and Stifel acted as book-running managers for the proposed offering.

A registration statement on Form S-1 relating to the shares sold in the initial public offering has been filed with the Securities and Exchange Commission and became effective on December 17, 2020.

908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it conducts research, designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.

You May Also Be Interested In